EMEA-000573-PIP02-13-M03
Key facts
| Invented name |
Vesicare and associated names
|
| Active substance |
Solifenacin (succinate)
|
| Therapeutic area |
Uro-nephrology
|
| Decision number |
P/0115/2015
|
| PIP number |
EMEA-000573-PIP02-13-M03
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of neurogenic detrusor overactivity
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Astellas Pharma Europe B.V.
|
| Decision type |
PM: decision on the application for modification of an agreed PIP
|
| Compliance procedure number |
EMEA-C-000573-PIP02-13-M03
|
| Compliance opinion date |
16/12/2016
|
| Compliance outcome |
positive
|